🌟 Join Our HYBRID Course on IMRT and VMAT: Best practices and new trends! 🌟
⏰ Don’t miss out and apply before the early deadline live course: 14 August 2024 and for the online course: 11 September 2024
👉Read more information and register : https://t.co/xvqNR4COFn
#radonc
The RTQA group visited USZ and PSI (Switzerland). Through the exchange of treatment experiences, these visits are of great value to the PROTECT study and the participating sites. All with the common goal of improving the treatment of esophageal cancer. (https://t.co/b7TozOGUaf)
First of the yearly RTQA meetings in the PROTECT trial. Great success with a lot of fantastic contributions and discussions. More than 40 participants. Thank you for joining. Looking forward to continued collaboration.
What a fantastic end to #FRPT2023 with @lone_hoffmann winning the best Poster presenter prize! 🙌
Looking forward to next year in Italy, I'm sure time will go by in a flash ⚡
#FLASHrt#FLASHradiotherapy
💙 Thank you for being a part of today's success—can't wait to continue sharing knowledge with you tomorrow. Until then, goodnight and see you soon!
#FRPT2023
My colleague Lars Praestegaard gave a great presentation of our work on the use of current transformer in eFLASH dosimetry at Aarhus university hospital
#FRPT2023
First 🇨🇭 oesophageal cancer patient enrolled into randomized PROTECT trial, comparing neoadjuvant Photon or Proton radiochemotherapy
👉 Strong collaboration between @psich_de and @Unispital_USZ@RadOncUSZ@CCCZ_USZ
https://t.co/yGekZ7lfUD
First day og ESTRO IMRT course. Particpants from 22 contries. We are in Turin - very nice city. Very excited to get started. Hope to get a lot of feed back from the students . #estro
Sådan💪- stor ros til Nationalt Forskningscenter for Stråleterapi for "Fremragende forskning, som bidrager til bedre strålebehandling af kræftpatienter i hele Danmark".
Centret er blevet til med støtte fra #Knækcancer#dkforsk#sundpol
https://t.co/SuBVOT5uwQ
Great and important talk on all the missing tools an "nice to have" tools in reirradiation. E.g the possibility to optimize new plan based on former plan in EQD2. @elivaos
Results from the ESTRO Physics reirradiation workshop 2022 showing large variety between dose accumulation in a large number of centres. Presented by @cancerphysicist and @elivaos